Anvisa Returns to Publishing Medical Device Price Monitoring Data
Anvisa (the National Health Surveillance Agency) has announced the resumption of the publication of medical device price monitoring data in its Business Intelligence (BI) panels. The activity, which had been temporarily suspended, is now back, with improvements to the process and guarantees of greater efficiency and precision.
ELS Group hosts webinar on the medicinal cannabis market in Europe
Join ELS Group for an Exclusive Discussion on the Future of Cannabis in Europe!
New Rules for Medicine Export Control in Portugal
INFARMED has introduced stricter export controls to prevent medicine shortages. Wholesale distributors must report exports, while manufacturers and pharmacies face less bureaucracy. These measures align with EU regulations, ensuring transparency and protecting national supply.
EMA Establishes Procedure for Scientific Advice on High-Risk Medical Devices
EMA has announced the implementation of a new standard procedure for scientific advice for manufacturers of high-risk medical devices.
European Commission Launches Public Consultation on Medical Devices and In Vitro Diagnostics Regulations
The European Commission has launched a public consultation on medical device regulations. Participate by March 21, 2025, and contribute to their evaluation.
FDA issues preliminary guidance for medical devices with Artificial Intelligence
First Guidance to Provide Comprehensive Recommendations for Artificial Intelligence in Medical Devices for Developers